OPTN (OptiNose, Inc.) Short-Term Debt to Capital

Corporate company logo of OptiNose, Inc. (OPTN)

OptiNose, Inc. (OPTN) management is striving to achieve profitability, which allows the current 0.00 metric to be tracked through the asset's market dynamics. The firm's profitability relies on the commercial success of XHANCE and the drug's recognition by insurance companies. Meanwhile, the company is optimizing expenses by outsourcing drug manufacturing, clinical research, and distribution to third-party contractors.

Ratio of Short-Term Indebtedness to Capital: Optinose (OPTN) for 07/04/2022 - 05/31/2025

Analytical breakdowns for OptiNose, Inc.

- stock quotes and analyst forecast:
Stock Price Optinose|OPTN - Fair Value Consensus
- business market valuation indicators:
Market Capitalization OptiNose Inc|OPTN - Enterprise Value
- book capitalization information:
Net Assets per Single Share OptiNose|OPTN - Accounting Value of Company|Market Value to Book Value Ratio optinose.com|OPTN - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital OptiNose, Inc.|OPTN - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio OptiNose|OPTN - Aggregate Debt Obligations|Debt to Book Capitalization Ratio OptiNose Inc|OPTN - Long-Term Debt|Company Current Liabilities OptiNose|Quick Ratio optinose.com
- company profitability and valuation multiples indicators:
OPTN - Final Profit
Fundamental valuation:OPTN Optinose
Brand item of OptiNose Inc

This indicator measures the proportion of short-term liabilities relative to equity, allowing for an assessment of liquidity gap risks by comparing current debt with the base value of assets. By analyzing changes in the short-term debt-to-equity ratio, an investor can determine the financial stability of OptiNose, Inc. (OPTN) as it scales its nasal technologies and licenses drug delivery systems to third-party pharmaceutical partners.

Competitors of OptiNose, Inc. (OPTN)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Amphastar AMPH|Pacira Corp (PCRX) - Current Liabilities to Capital|SPRY: Short-Term Debt to Equity Ratio|theravance.com - Short-Term Loans to Capital Ratio|AQST: Short-Term Debt to Capital|scPharmaceuticals - Ratio of Short-Term Indebtedness to Capital|TECX (Tectonic Therapeutic Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital Tonix Pharmaceuticals Holding TNXP|Short-Term Debt to Equity China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Current Liabilities to Capital|ORMP - Short-Term Debt to Equity|Current Liabilities to Equity ENTX|HYFT (MindWalk Holdings) - Short-Term Debt to Equity Ratio|ABVC: Short-Term Loans to Capital Ratio|CPIX (Cumberland Pharmaceuticals Inc.) - Short-Term Debt to Capital|Quantum BioPharma Ltd. (QNTM) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity FibroGen Corp (FGEN)|Telomir Pharmaceuticals Corp - Short-Term Debt to Capital Ratio|Short-Term Debt to Equity Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp. (SNYR) - Current Liabilities to Capital|RLYB - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient Lexaria Bioscience LEXX|PULM: Short-Term Debt to Capital|Current Liabilities to Capital Pheton Holdings (PTHL)|Short-Term Debt to Equity Ratio APM|LYRA: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital IBO|Short-Term Debt to Capital Coefficient tnfpharma.com|Short-Term Debt to Equity cbdMD YCBD|PRFX: Short-Term Debt to Capital Ratio|Auris Medical - Short-Term Debt to Capital|lipella.com (LIPO) - Short-Term Debt to Equity Ratio|PIRS (Pieris Pharmaceuticals, Inc.) - Short-Term Debt to Equity Ratio|PROC - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Petros|Current Liabilities to Capital Qilian International Corp QLI|Short-Term Debt to Equity Acelyrin, Inc. (SLRN)|TFFP: Current Liabilities to Equity